603 related articles for article (PubMed ID: 15556624)
41. Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour model.
Dubois L; Lieuwes NG; Maresca A; Thiry A; Supuran CT; Scozzafava A; Wouters BG; Lambin P
Radiother Oncol; 2009 Sep; 92(3):423-8. PubMed ID: 19616332
[TBL] [Abstract][Full Text] [Related]
42. Designing carbonic anhydrase inhibitors for the treatment of breast cancer.
Supuran CT; Winum JY
Expert Opin Drug Discov; 2015 Jun; 10(6):591-7. PubMed ID: 25891195
[TBL] [Abstract][Full Text] [Related]
43. Assessment of carbonic anhydrase IX expression and extracellular pH in B-cell lymphoma cell line models.
Chen LQ; Howison CM; Spier C; Stopeck AT; Malm SW; Pagel MD; Baker AF
Leuk Lymphoma; 2015 May; 56(5):1432-9. PubMed ID: 25130478
[TBL] [Abstract][Full Text] [Related]
44. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.
Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
Bioorg Med Chem Lett; 2004 Nov; 14(21):5427-33. PubMed ID: 15454239
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and biological evaluation of a 99mTc-labelled sulfonamide conjugate for in vivo visualization of carbonic anhydrase IX expression in tumor hypoxia.
Akurathi V; Dubois L; Lieuwes NG; Chitneni SK; Cleynhens BJ; Vullo D; Supuran CT; Verbruggen AM; Lambin P; Bormans GM
Nucl Med Biol; 2010 Jul; 37(5):557-64. PubMed ID: 20610160
[TBL] [Abstract][Full Text] [Related]
46. Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis.
Haapasalo JA; Nordfors KM; Hilvo M; Rantala IJ; Soini Y; Parkkila AK; Pastoreková S; Pastorek J; Parkkila SM; Haapasalo HK
Clin Cancer Res; 2006 Jan; 12(2):473-7. PubMed ID: 16428489
[TBL] [Abstract][Full Text] [Related]
47. Expression and activity of carbonic anhydrase IX is associated with metabolic dysfunction in MDA-MB-231 breast cancer cells.
Li Y; Wang H; Oosterwijk E; Tu C; Shiverick KT; Silverman DN; Frost SC
Cancer Invest; 2009 Jul; 27(6):613-23. PubMed ID: 19367501
[TBL] [Abstract][Full Text] [Related]
48. Understanding metabolic alterations and heterogeneity in cancer progression through validated immunodetection of key molecular components: a case of carbonic anhydrase IX.
Takacova M; Kajanova I; Kolarcikova M; Lapinova J; Zatovicova M; Pastorekova S
Cancer Metastasis Rev; 2021 Dec; 40(4):1035-1053. PubMed ID: 35080763
[TBL] [Abstract][Full Text] [Related]
49. Carbonic anhydrase IX expression correlates with FDG uptake by primary non-small cell lung cancer.
Mees G; Vangestel C; Dierckx R; Pauwels P; Van Meerbeeck J; Van de Wiele C
Cancer Biother Radiopharm; 2010 Apr; 25(2):149-54. PubMed ID: 20423227
[TBL] [Abstract][Full Text] [Related]
50. Carbonic anhydrase inhibitors: design of spin-labeled sulfonamides incorporating TEMPO moieties as probes for cytosolic or transmembrane isozymes.
Cecchi A; Ciani L; Winum JY; Montero JL; Scozzafava A; Ristori S; Supuran CT
Bioorg Med Chem Lett; 2008 Jun; 18(12):3475-80. PubMed ID: 18513964
[TBL] [Abstract][Full Text] [Related]
51. Carbonic anhydrase IX: a new druggable target for the design of antitumor agents.
Winum JY; Rami M; Scozzafava A; Montero JL; Supuran C
Med Res Rev; 2008 May; 28(3):445-63. PubMed ID: 17880011
[TBL] [Abstract][Full Text] [Related]
52. A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells.
Mboge MY; Chen Z; Khokhar D; Wolff A; Ai L; Heldermon CD; Bozdag M; Carta F; Supuran CT; Brown KD; McKenna R; Frost CJ; Frost SC
Biochem J; 2019 May; 476(10):1497-1513. PubMed ID: 31072911
[TBL] [Abstract][Full Text] [Related]
53. Selective carbonic anhydrase IX inhibitors based on coumarin scaffold as promising antimetastatic agents: WO2012070024.
Carradori S
Expert Opin Ther Pat; 2013; 23(6):751-6. PubMed ID: 23387899
[TBL] [Abstract][Full Text] [Related]
54. Rapid detection of the hypoxia-regulated CA-IX and NDRG1 gene expression in different glioblastoma cells in vitro.
Said HM; Polat B; Staab A; Hagemann C; Stein S; Flentje M; Theobald M; Katzer A; Vordermark D
Oncol Rep; 2008 Aug; 20(2):413-9. PubMed ID: 18636206
[TBL] [Abstract][Full Text] [Related]
55. Carbonic anhydrase inhibitors: bioreductive nitro-containing sulfonamides with selectivity for targeting the tumor associated isoforms IX and XII.
D'Ambrosio K; Vitale RM; Dogné JM; Masereel B; Innocenti A; Scozzafava A; De Simone G; Supuran CT
J Med Chem; 2008 Jun; 51(11):3230-7. PubMed ID: 18481843
[TBL] [Abstract][Full Text] [Related]
56. Expression of hypoxic marker carbonic anhydrase IX predicts poor prognosis in resectable hepatocellular carcinoma.
Huang WJ; Jeng YM; Lai HS; Fong IU; Sheu FY; Lai PL; Yuan RH
PLoS One; 2015; 10(3):e0119181. PubMed ID: 25738958
[TBL] [Abstract][Full Text] [Related]
57. Carbonic anhydrase IX interacts with bicarbonate transporters in lamellipodia and increases cell migration via its catalytic domain.
Svastova E; Witarski W; Csaderova L; Kosik I; Skvarkova L; Hulikova A; Zatovicova M; Barathova M; Kopacek J; Pastorek J; Pastorekova S
J Biol Chem; 2012 Jan; 287(5):3392-402. PubMed ID: 22170054
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and SAR of novel Re/99mTc-labeled benzenesulfonamide carbonic anhydrase IX inhibitors for molecular imaging of tumor hypoxia.
Lu G; Hillier SM; Maresca KP; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
J Med Chem; 2013 Jan; 56(2):510-20. PubMed ID: 23234246
[TBL] [Abstract][Full Text] [Related]
59. Development of small molecule carbonic anhydrase IX inhibitors.
Supuran CT
BJU Int; 2008 Jun; 101 Suppl 4():39-40. PubMed ID: 18430122
[No Abstract] [Full Text] [Related]
60. Expression of carbonic anhydrase IX in craniopharyngiomas.
Proescholdt M; Merrill M; Stoerr EM; Lohmeier A; Dietmaier W; Brawanski A
J Neurosurg; 2011 Oct; 115(4):796-801. PubMed ID: 21761968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
